Post# 112 of 114 Dermata Therapeutics GAAP EPS of -$2.27 May 11, 2023 5:44 PM ETDermata Therapeutics, Inc. (DRMA)By: Gaurav Batavia, SA News Editor Dermata Therapeutics press release (NASDAQ:DRMA): Q1 GAAP EPS of -$2.27. As of March 31, 2023, Dermata had $8.8 million in cash and cash equivalents, compared to $6.2 million as of December 31, 2022.
for some sick reason they did an small offering hence the steep dip,with phase 3 catalyst in cards. i will double up next 2 weeks and wait
its peers all did big pops, buy solid biotechs.wait for it to unfold
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.